Stay updated on Metformin in Longevity Study (MILES) Clinical Trial
Sign up to get notified when there's something new on the Metformin in Longevity Study (MILES) Clinical Trial page.

Latest updates to the Metformin in Longevity Study (MILES) Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedLocations/New York added; revision updated to v3.3.3. HHS Vulnerability Disclosure and New York Locations removed; revision updated from v3.3.2.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved a general operating status notice about funding lapse from the page. The study details, eligibility criteria, and contact information remain unchanged.SummaryDifference0.4%

- Check64 days agoChange DetectedAn updated last update date (2021-05-21) appears in the Study Record Dates, indicating a revision to the record. The page retains results-related entries showing ongoing updates to results information.SummaryDifference0.4%

- Check93 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

- Check100 days agoChange DetectedAdded version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these deletions are intended, this is a major reduction in detailed drug-safety content.SummaryDifference0.5%

Stay in the know with updates to Metformin in Longevity Study (MILES) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Metformin in Longevity Study (MILES) Clinical Trial page.